312 related articles for article (PubMed ID: 23402253)
21. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
Ammar AS; Mahmoud KM; Kasemy ZA
Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
[TBL] [Abstract][Full Text] [Related]
22. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
[TBL] [Abstract][Full Text] [Related]
23. Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing.
Eikermann M; Zaremba S; Malhotra A; Jordan AS; Rosow C; Chamberlin NL
Br J Anaesth; 2008 Sep; 101(3):344-9. PubMed ID: 18559352
[TBL] [Abstract][Full Text] [Related]
24. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
[TBL] [Abstract][Full Text] [Related]
25. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
26. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
[TBL] [Abstract][Full Text] [Related]
27. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
de Boer HD; van Esmond J; Booij LH; Driessen JJ
Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
[TBL] [Abstract][Full Text] [Related]
28. [Indications and clinical use of sugammadex].
Debaene B; Meistelman C
Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S57-63. PubMed ID: 19887279
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
Carron M; Zarantonello F; Tellaroli P; Ori C
J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
[TBL] [Abstract][Full Text] [Related]
30. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
Shields M; Giovannelli M; Mirakhur RK; Moppett I; Adams J; Hermens Y
Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
[TBL] [Abstract][Full Text] [Related]
31. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
[TBL] [Abstract][Full Text] [Related]
32. Sugammadex given for rocuronium-induced neuromuscular blockade in infants: a retrospectıve study.
Ozmete O; Bali C; Cok OY; Turk HE; Ozyilkan NB; Civi S; Aribogan A
J Clin Anesth; 2016 Dec; 35():497-501. PubMed ID: 27871583
[TBL] [Abstract][Full Text] [Related]
33. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
[TBL] [Abstract][Full Text] [Related]
34. Sugammadex in anesthesia practice.
Duvaldestin P; Plaud B
Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
[TBL] [Abstract][Full Text] [Related]
36. Sugammadex-rocuronium dosing.
Kopman AF
Anesth Analg; 2007 Sep; 105(3):883-4; author reply 884. PubMed ID: 17717263
[No Abstract] [Full Text] [Related]
37. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacology of sugammadex].
Meistelman C; Fuchs-Buder T
Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S51-6. PubMed ID: 19887278
[TBL] [Abstract][Full Text] [Related]
39. [Does rocuronium displace the position of suxamethonium?].
Sasakawa T; Iwasaki H
Masui; 2008 Jul; 57(7):860-8. PubMed ID: 18649641
[TBL] [Abstract][Full Text] [Related]
40. [Reversal of rocuronium-induced neuromuscular blockade with sugammadex in patients for cesarean delivery treated with magnesium sulfate].
Sakurai Y; Uchida M; Aiba J; Mimura F; Yamaguchi M; Kakumoto M
Masui; 2014 Mar; 63(3):315-9. PubMed ID: 24724442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
